Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ASKC-202 by Jiangsu Aosaikang Pharmaceutical for Lung Cancer: Likelihood of Approval
ASKC-202 is under clinical development by Jiangsu Aosaikang Pharmaceutical and currently in Phase I for Lung Cancer. According to GlobalData,...